Advertisement
Advertisement

CNMD

CNMD logo

CONMED Corporation

33.83
USD
Sponsored
0.00
0.00%
Jul 03, 09:30 UTC -4
Closed
exchange

After-Market

33.84

+0.02
+0.04%

CONMED Corporation Profile

About

CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. A significant portion of the company's revenues are derived from products designed for the orthopedic surgery markets of arthroscopy and powered surgical instruments. The company also sells products for general and other surgical specialties such as electrosurgery systems for all types of surgery, and endosurgery instruments for minimally invasive laparoscopic surgery. Patient Care products, including ECG electrodes for heart monitoring and pulse oximetry for blood oxygenation monitoring, are provided for various clinical settings.The company operates in two revenue segments: Orthopedic Surgery and General Surgery.

Info & Links

CEO

Patrick J. Beyer

Headquarters

11311 CONCEPT BOULEVARD
LARGO, FL 33773, UNITED STATES

Industry

Medical Dental Supplies

Sector

Medical

Website

www.conmed.com

Auditor

PricewaterhouseCoopers LLP

Share holders

432

Employees

3,900

CONMED Corporation Statistics

Valuation Measures

Market Capitalization2

1.02B

Enterprise Value

1.84B

Enterprise Value/EBITDA(ttm)

9.59

Price to Earnings Ratio(ttm)

8.01

Price to Sales(ttm)

0.81

Price to Book(mrq)

1.11

Price to Cash(ytd)

5.13

Profitability

Gross Margin(ttm)

54.50%

Operating Margin(ttm)

10.41%

Profit Margin(ttm)

3.37%

Return on Equity(ttm)

14.23%

Return on Invested Capital(ttm)

2.51%

Return on Assets(ttm)

6.17%

Income Statement

Revenue(ttm)

1.37B

Revenue Per Share(ttm)

45.52

Gross Profit(ttm)

756.17M

EBITDA(ttm)3

192.42M

Net Income Available to Common(ttm)

54.85M

Diluted EPS(ttm)

1.51

Share Statistics

Beta (5Y Monthly)

0.99

52-Week Change

-37.73%

S&P 500 52-Week Change

20.12%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

30.11M

Dividend Yield

0.00%

Float4

29.21M

% Held by Insiders

3.10%

% Held by Institutions

--

Balance Sheet

Total Cash(mrq)

35.03M

Total Cash Per Share(mrq)

1.16

Total Debt(mrq)

860.87M

Total Debt/Equity(mrq)

80.82%

Current Ratio(mrq)

2.14%

Quick Ratio(mrq)

1.01%

Book Value Per Share(mrq)

33.36

Cash Flow

Operating Cash Flow Per Share(ytd)

5.48

Free Cash Flow(ytd)

150.88M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement